MCIA and AMCA – A Unified Voice for the Medicinal Cannabis Industry

Joint Media Release for Cannabiz

The two leading industry associations in the medicinal cannabis sector, Australian Medicinal Cannabis Association (AMCA) and Medicinal Cannabis Industry Association (MCIA) are delighted to announce their intention to collaborate more closely for the benefit of their members and the medicinal cannabis sector as a whole and to facilitate interactions with government bodies and other stakeholders as one unified voice.

Continue reading “MCIA and AMCA – A Unified Voice for the Medicinal Cannabis Industry”

MCIA welcomes ATMAC grant to boost medicinal cannabis exports

In a first for the medicinal cannabis industry, Medicinal Cannabis Industry Australia (MCIA), the peak body for Australia’s medicinal cannabis industry, has been awarded a $250,000 Agricultural Trade and Market Access Cooperation (ATMAC) grant to assist Australian medicinal cannabis companies in securing global markets for medicinal cannabis products.

Continue reading “MCIA welcomes ATMAC grant to boost medicinal cannabis exports”

MCIA launches Olivia Newton-John Service to Industry Award to recognise excellence in the medicinal cannabis industry

“The Medicinal Cannabis Industry Australia is pleased and excited to launch the Olivia Newton-John Service to Industry award”, said Mr Peter Crock, MCIA Chair, “and we are particularly honoured to have Olivia’s husband Mr John Easterling with us at ACannabis to formerly open the call for nominations for the inaugural 2023 Service to Industry Award”.

Continue reading “MCIA launches Olivia Newton-John Service to Industry Award to recognise excellence in the medicinal cannabis industry”

MCIA and Epilepsy Action Australia partner to deliver independent information for the medicinal cannabis industry

Medicinal Cannabis Industry Australia (MCIA) is the voice for Australia’s medicinal cannabis industry and is focused on representing the mutual interests of members to build a sustainable and responsible industry that is trusted, valued, puts patients first and recognised for its quality and innovation.

Epilepsy Action Australia (EAA) as the leading and oldest provider of epilepsy services nationwide, focuses on improving self-management skills, increasing wider public understanding of this devastating condition, and are at the forefront of partnering and funding research into interventions and treatments. EAA also operate CanGuide, an independent and impartial service providing information on cannabis-based medicine.

Continue reading “MCIA and Epilepsy Action Australia partner to deliver independent information for the medicinal cannabis industry”

MCIA investigations shine further light on Australia’s medicinal cannabis industry

In October MCIA released data obtained from the Office of Drug Control that revealed the volume of medicinal cannabis produced by Australian cultivators, along with volumes of imports and exports. MCIA has now obtained data from TGA that sheds light on the nature of products sold in Australia.

Continue reading “MCIA investigations shine further light on Australia’s medicinal cannabis industry”